• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国人原发性高草酸尿症 3 型中 HOGA1 基因突变热点区域。

Mutation Hot Spot Region in the HOGA1 Gene Associated with Primary Hyperoxaluria Type 3 in the Chinese Population.

机构信息

Department of Urology, Beijing Friendship Hospital, Capital Medical University, Beijing, China.

Department of Pediatrics, Peking University First Hospital, Beijing, China.

出版信息

Kidney Blood Press Res. 2019;44(4):743-753. doi: 10.1159/000501458. Epub 2019 Aug 9.

DOI:10.1159/000501458
PMID:31401635
Abstract

BACKGROUND

Primary hyperoxaluria type 3 (PH3) is a rare autosomal recessive disorder that affects glyoxylate metabolism. PH3 is caused by defects in 4-hydroxy-2-oxoglutarate aldolase, which is encoded by the HOGA1 gene. However, only 3 cases of PH3 have been described in Asians until today. This study aimed to determine the clinical and mutation spectra of patients from mainland China with PH3.

METHODS

We applied targeted next-generation sequencing to four non-consanguineous, unrelated Chinese families with PH3 to identify the genes hosting disease-causing mutations. This approach was confirmed by Sanger sequencing.

RESULTS

Five patients (2 boys and 3 girls) from four unrelated Chinese families were admitted because of kidney stones. Five HOGA1 gene sequence mutations were detected, including two novel mutations, c.811C>T (p.R271C) and c.812G>A (p.R271H). These compound heterozygous mutations were detected in a female PH3 patient (patient 4). Other patients included 2 boys who had heterozygous c.834_834+1GG>TT and c.834G>A (p.A278A) mutations (patients 1 and 2), a girl with homozygous c.834G>A (p.A278A) mutation (patient 3), and a girl with heterozygous c.834_834+1GG>TT and c.346C>T (p.Q116X) mutations (patient 5). The mutations in the c.834_834+1 region, including c.834G>A, c.834+1G>T, and c.834_834+1GG>TT, account for 5/8 of alleles in our study and 3/4 of alleles reported among Chinese patients. All patients in this study received hyperhydration and urine alkalinization treatment.

CONCLUSION

Five PH3 cases were reported. Potential mutation hot spot region (c.834_834+1) in the Chinese population and two novel mutations were found.

摘要

背景

原发性高草酸尿症 3 型(PH3)是一种罕见的常染色体隐性遗传疾病,影响乙醛酸代谢。PH3 是由 4-羟基-2-氧代戊二酸醛缩酶缺陷引起的,该酶由 HOGA1 基因编码。然而,直到今天,亚洲仅报道了 3 例 PH3 病例。本研究旨在确定中国大陆 PH3 患者的临床和突变谱。

方法

我们应用靶向下一代测序技术对 4 个非近亲、无关的 PH3 中国家庭进行分析,以鉴定致病突变基因。该方法通过 Sanger 测序进行了验证。

结果

来自 4 个无关中国家庭的 5 名患者(2 名男孩和 3 名女孩)因肾结石而入院。在 5 名患者中检测到 5 种 HOGA1 基因突变,包括 2 种新突变,c.811C>T(p.R271C)和 c.812G>A(p.R271H)。这些复合杂合突变在一名 PH3 女性患者(患者 4)中被发现。其他患者包括 2 名男孩,他们分别携带杂合 c.834_834+1GG>TT 和 c.834G>A(p.A278A)突变(患者 1 和 2),一名女孩携带纯合 c.834G>A(p.A278A)突变(患者 3),以及一名女孩携带杂合 c.834_834+1GG>TT 和 c.346C>T(p.Q116X)突变(患者 5)。c.834_834+1 区域的突变,包括 c.834G>A、c.834+1G>T 和 c.834_834+1GG>TT,占本研究中 8 个等位基因的 5/8 和中国患者报告的 4 个等位基因的 3/4。本研究中所有患者均接受了水化和尿液碱化治疗。

结论

报告了 5 例 PH3 病例。在中国人群中发现了潜在的突变热点区域(c.834_834+1)和 2 种新突变。

相似文献

1
Mutation Hot Spot Region in the HOGA1 Gene Associated with Primary Hyperoxaluria Type 3 in the Chinese Population.中国人原发性高草酸尿症 3 型中 HOGA1 基因突变热点区域。
Kidney Blood Press Res. 2019;44(4):743-753. doi: 10.1159/000501458. Epub 2019 Aug 9.
2
Two Novel HOGA1 Splicing Mutations Identified in a Chinese Patient with Primary Hyperoxaluria Type 3.在中国一名原发性3型高草酸尿症患者中鉴定出两种新型HOGA1剪接突变。
Am J Nephrol. 2015;42(1):78-84. doi: 10.1159/000439232.
3
Nine novel HOGA1 gene mutations identified in primary hyperoxaluria type 3 and distinct clinical and biochemical characteristics in Chinese children.在中国儿童中发现的 3 型原发性高草酸尿症中 9 种新型 HOGA1 基因突变及不同的临床和生化特征。
Pediatr Nephrol. 2019 Oct;34(10):1785-1790. doi: 10.1007/s00467-019-04279-7. Epub 2019 May 23.
4
HOGA1 variants in Chinese patients with primary hyperoxaluria type 3: genetic features and genotype-phenotype relationships.中国人原发性高草酸尿症 3 型患者中 HOGA1 变异体:遗传特征和基因型-表型关系。
World J Urol. 2023 Aug;41(8):2141-2148. doi: 10.1007/s00345-023-04461-5. Epub 2023 Jun 15.
5
HOGA1 Gene Mutations of Primary Hyperoxaluria Type 3 in Tunisian Patients.突尼斯患者原发性高草酸尿症3型的HOGA1基因突变
J Clin Lab Anal. 2017 May;31(3). doi: 10.1002/jcla.22053. Epub 2016 Aug 26.
6
Renal function can be impaired in children with primary hyperoxaluria type 3.3型原发性高草酸尿症患儿的肾功能可能受损。
Pediatr Nephrol. 2015 Oct;30(10):1807-13. doi: 10.1007/s00467-015-3090-x. Epub 2015 May 14.
7
Updated genetic testing of Italian patients referred with a clinical diagnosis of primary hyperoxaluria.对临床诊断为原发性高草酸尿症的意大利患者进行的基因检测更新。
J Nephrol. 2017 Apr;30(2):219-225. doi: 10.1007/s40620-016-0287-4. Epub 2016 Mar 5.
8
The enzyme 4-hydroxy-2-oxoglutarate aldolase is deficient in primary hyperoxaluria type 3.该酶 4-羟基-2-氧代戊二酸醛缩酶在原发性高草酸尿症 3 型中缺乏。
Nephrol Dial Transplant. 2012 Aug;27(8):3191-5. doi: 10.1093/ndt/gfs039. Epub 2012 Mar 5.
9
A Putative Mutation Hotspot of the AGXT Gene Associated with Primary Hyperoxaluria Type 1 in the Chinese Population.中国人群中与1型原发性高草酸尿症相关的AGXT基因的一个假定突变热点
Tohoku J Exp Med. 2018 Dec;246(4):233-241. doi: 10.1620/tjem.246.233.
10
Primary hyperoxaluria type III gene HOGA1 (formerly DHDPSL) as a possible risk factor for idiopathic calcium oxalate urolithiasis.III 型原发性高草酸尿症基因 HOGA1(以前称为 DHDPSL)可能是特发性草酸钙尿石症的一个风险因素。
Clin J Am Soc Nephrol. 2011 Sep;6(9):2289-95. doi: 10.2215/CJN.02760311.

引用本文的文献

1
Genotype and Phenotype Characteristics of Chinese Pediatric Patients with Primary Hyperoxaluria.中国原发性高草酸尿症儿科患者的基因型和表型特征
Hum Mutat. 2023 Sep 14;2023:4875680. doi: 10.1155/2023/4875680. eCollection 2023.
2
HOGA1 Suppresses Renal Cell Carcinoma Growth via Inhibiting the Wnt/β-Catenin Signalling Pathway.HOGA1通过抑制Wnt/β-连环蛋白信号通路抑制肾细胞癌生长。
J Cell Mol Med. 2025 Mar;29(6):e70490. doi: 10.1111/jcmm.70490.
3
Mutation Characteristics of Primary Hyperoxaluria in the Chinese Population and Current International Diagnosis and Treatment Status.
中国人群原发性高草酸尿症的突变特征及当前国际诊断与治疗现状
Kidney Dis (Basel). 2024 Jun 17;10(4):313-326. doi: 10.1159/000539516. eCollection 2024 Aug.
4
HOGA1 variants in Chinese patients with primary hyperoxaluria type 3: genetic features and genotype-phenotype relationships.中国人原发性高草酸尿症 3 型患者中 HOGA1 变异体:遗传特征和基因型-表型关系。
World J Urol. 2023 Aug;41(8):2141-2148. doi: 10.1007/s00345-023-04461-5. Epub 2023 Jun 15.
5
Nedosiran in primary hyperoxaluria subtype 3: results from a phase I, single-dose study (PHYOX4).尼多西兰治疗 3 型原发性高草酸尿症:一项 I 期、单次剂量研究(PHYOX4)的结果。
Urolithiasis. 2023 Apr 28;51(1):80. doi: 10.1007/s00240-023-01453-3.
6
Nedosiran, a Candidate siRNA Drug for the Treatment of Primary Hyperoxaluria: Design, Development, and Clinical Studies.奈多司然,一种用于治疗原发性高草酸尿症的小干扰RNA候选药物:设计、研发及临床研究
ACS Pharmacol Transl Sci. 2022 Sep 21;5(11):1007-1016. doi: 10.1021/acsptsci.2c00110. eCollection 2022 Nov 11.
7
Possible ethnic associations in primary hyperoxaluria type-III-associated HOGA1 sequence variants.可能与原发性高草酸尿症 III 型相关的 HOGA1 序列变异存在种族相关性。
Mol Biol Rep. 2021 Apr;48(4):3841-3844. doi: 10.1007/s11033-021-06380-3. Epub 2021 May 4.